223 related articles for article (PubMed ID: 16913706)
1. Synthesis and cytotoxic activity of polyamine analogues of camptothecin.
Dallavalle S; Giannini G; Alloatti D; Casati A; Marastoni E; Musso L; Merlini L; Morini G; Penco S; Pisano C; Tinelli S; De Cesare M; Beretta GL; Zunino F
J Med Chem; 2006 Aug; 49(17):5177-86. PubMed ID: 16913706
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic activity of substituted 7-aryliminomethyl derivatives of camptothecin.
Dallavalle S; Merlini L; Morini G; Musso L; Penco S; Beretta GL; Tinelli S; Zunino F
Eur J Med Chem; 2004 Jun; 39(6):507-13. PubMed ID: 15183909
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.
Nagarajan M; Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
J Med Chem; 2003 Dec; 46(26):5712-24. PubMed ID: 14667224
[TBL] [Abstract][Full Text] [Related]
4. The role of polyamine architecture on the pharmacological activity of open lactone camptothecin-polyamine conjugates.
Samorì C; Guerrini A; Varchi G; Beretta GL; Fontana G; Bombardelli E; Carenini N; Zunino F; Bertucci C; Fiori J; Battaglia A
Bioconjug Chem; 2008 Nov; 19(11):2270-9. PubMed ID: 18839979
[TBL] [Abstract][Full Text] [Related]
5. Biological properties of IDN5174, a new synthetic camptothecin with the open lactone ring.
Beretta GL; Petrangolini G; De Cesare M; Pratesi G; Perego P; Tinelli S; Tortoreto M; Zucchetti M; Frapolli R; Bello E; Manzotti C; Fontana G; Bombardelli E; Battaglia A; Samorì C; Zunino F
Cancer Res; 2006 Nov; 66(22):10976-82. PubMed ID: 17108136
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
Zhao R; al-Said NH; Sternbach DL; Lown JW
J Med Chem; 1997 Jan; 40(2):216-25. PubMed ID: 9003520
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new camptothecin analogs with improved antitumor activities.
Niizuma S; Tsukazaki M; Suda H; Murata T; Ohwada J; Ozawa S; Fukuda H; Murasaki C; Kohchi M; Morikami K; Yoshinari K; Endo M; Ura M; Tanimura H; Miyazaki Y; Takasuka T; Kawashima A; Nanba E; Nakano K; Ogawa K; Kobayashi K; Okabe H; Umeda I; Shimma N
Bioorg Med Chem Lett; 2009 Apr; 19(7):2018-21. PubMed ID: 19254843
[TBL] [Abstract][Full Text] [Related]
9. Camptothecin: current perspectives.
Thomas CJ; Rahier NJ; Hecht SM
Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activity of new 9-substituted camptothecins.
Dallavalle S; Rocchetta DG; Musso L; Merlini L; Morini G; Penco S; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 May; 18(9):2781-7. PubMed ID: 18434153
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 10,11-methylenedioxy-14-azacamptothecin.
Elban MA; Sun W; Eisenhauer BM; Gao R; Hecht SM
Org Lett; 2006 Aug; 8(16):3513-6. PubMed ID: 16869648
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.
Fox BM; Xiao X; Antony S; Kohlhagen G; Pommier Y; Staker BL; Stewart L; Cushman M
J Med Chem; 2003 Jul; 46(15):3275-82. PubMed ID: 12852757
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.
Wang X; Wang LK; Kingsbury WD; Johnson RK; Hecht SM
Biochemistry; 1998 Jun; 37(26):9399-408. PubMed ID: 9649322
[TBL] [Abstract][Full Text] [Related]
15. Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity.
Sukhanova A; Grokhovsky S; Zhuze A; Devy J; Pluot M; Oleinikov V; Nabiev I
Anticancer Res; 2003; 23(3B):2609-15. PubMed ID: 12894548
[TBL] [Abstract][Full Text] [Related]
16. Hydrophilic camptothecin analogs that form extremely stable cleavable complexes with DNA and topoisomerase I.
Wadkins RM; Bearss D; Manikumar G; Wani MC; Wall ME; Von Hoff DD
Cancer Res; 2004 Sep; 64(18):6679-83. PubMed ID: 15374984
[TBL] [Abstract][Full Text] [Related]
17. E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluation.
Giannini G; Marzi M; Cabri W; Marastoni E; Battistuzzi G; Vesci L; Pisano C; Beretta GL; De Cesare M; Zunino F
Bioorg Med Chem Lett; 2008 May; 18(9):2910-5. PubMed ID: 18424133
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship study of 16 a-thiocamptothecins: an integrated in vitro and in silico approach.
Samorì C; Beretta GL; Varchi G; Guerrini A; Di Micco S; Basili S; Bifulco G; Riccio R; Moro S; Bombardelli E; Zunino F; Fontana G
ChemMedChem; 2010 Dec; 5(12):2006-15. PubMed ID: 21069656
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of a folate peptide camptothecin prodrug.
Henne WA; Doorneweerd DD; Hilgenbrink AR; Kularatne SA; Low PS
Bioorg Med Chem Lett; 2006 Oct; 16(20):5350-5. PubMed ID: 16901694
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.
Zhu L; Zhuang C; Lei N; Guo Z; Sheng C; Dong G; Wang S; Zhang Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2012 Oct; 56():1-9. PubMed ID: 23084702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
